This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05382286
Brief Title: Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-04)

First Submitted : May 16, 2022
First Submitted that Met QC Criteria : May 16, 2022
First Posted : May 19, 2022

Last Update Submitted that Met QC Criteria : March 26, 2024
Last Update Posted : March 28, 2024